Eapen, MD, notes, Dosage must not be increased by more than 2.5 mg at a time, and keeping a minimum of 4 weeks between dose changes is recommended
Injectable Wegovy costs $349 per month depending on the dose, though Novo Nordisk is offering promotional pricing of $199 for the first two months through March 2026
This combination therapy is expected to achieve a 15% reduction in body weight after 32 weeks, offering a significant improvement over existing treatments
It is expansion of the entire GLP-1 market Access vs readiness gap Affordability is improving faster than systems for awareness, adherence, and monitoring Execution will define winners Beyond pricing, success will depend on physician trust, patient journeys, and real-world outcomes Shift in pharma playbook From innovation-led launches to access-led scaling strategies This is one of the rare moments where generics dont just erode value